Industry Insights Logo

340B Compliance Workshop: In-Depth Training on 340B Program Requirements and Developments

SPONSORED CONTENT

340B program compliance seems to become more complicated each year, with new reporting obligations, scrutiny and expectations. Even seasoned 340B program health center staff can feel overwhelmed by the volume and pace of developments in the

Read More »
340B Solutions Spotlight

Q: What is the primary problem Accelerate Pharmacy Solutions solves?

Accelerate Pharmacy Solutions 340B Consulting helps healthcare organizations address the operational, financial, and compliance complexity of…

Read More »
Industry Insights Logo

Why Finding a 340B Referral Isn’t the Same as Capturing It

SPONSORED CONTENT

Artificial Intelligence (AI) is reshaping 340B referral capture, and it is only ramping up from here. I have seen that firsthand working with hundreds of covered entities (CE) over the last four years. Here is what AI does well:

  • Identifying referral
Read More »
Industry Insights Logo

Referral Documentation Defensibility

SPONSORED CONTENT

Covered entities participating in the 340B program continue to operate in an environment of increasing complexity and scrutiny. As regulatory expectations evolve, one area that has emerged as a critical point of vulnerability is referral

Read More »

Q: What is the primary problem 340BCheck solves?

Covered entities (CEs) face growing 340B compliance risk but lack the tools to keep pace with…

Read More »
Industry Insights Logo

Navigating Maximum Fair Price (MFP) & Other Regulatory Challenges with a Proven Strategy

SPONSORED CONTENT

In addition to the insights offered below, 340B Report readers are invited to attend CPS’ upcoming webinar Wednesday, September 16, 2026, for a deeper dive into industry changes and new/updated government policies. This live Q&A session will offer

Read More »
Industry Insights Logo

Pay First, Rebate Later: The New Reality of 340B

SPONSORED CONTENT

Rebates are nothing new in the prescription-drug market. What is new is their potential role in 340B. HRSA’s revised voluntary 340B Rebate Model Pilot represents a significant change in

Read More »
Industry Insights Logo

CMS 2027 Proposed Rules Signal Significant Changes for 340B Covered Entities

SPONSORED CONTENT

The recently released CMS CY 2027 Hospital Outpatient Prospective Payment System (OPPS) and Medicare Physician Fee Schedule (PFS) proposed rules contain several provisions that could have significant operational and financial implications for 340B covered entities (CEs). While the

Read More »
Industry Insights Logo

The Essential Role of a Location Crosswalk in 340B Program Management

SPONSORED CONTENT

For health systems participating in the 340B Drug Pricing Program, maintaining compliance and optimizing operations are top priorities. One essential tool in achieving these goals is the development of a location crosswalk, especially important for Covered Entities (CEs) with

Read More »
Industry Insights Logo

Webinar–The 340B Rebate Model Is Officially Moving Forward. What Happens Next?

SPONSORED CONTENT

The revised 340B Rebate Model is moving forward, and with implementation now scheduled for January 1, 2027, covered entities have entered a new phase of preparation. While many questions remain, one thing is clear: organizations should begin evaluating the

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Site Footer Live